Skip to main content
Atrás
Watch Compare

MIRA PHARMACEUTICALS, INC.

Calidad de datos: 83%
MIRA
Nasdaq Manufacturing Chemicals
$1.03
▼ $0.01 (-0.96%)
Cap. Mercado: 43.28 M
Precio
$1.03
Cap. Mercado
43.28 M
Rango del Día
$1.02 — $1.07
Rango de 52 Semanas
$0.82 — $2.45
Volumen
74,261
Apertura $1.04
Promedio 50D / 200D
$1.18
13.01% below
Promedio 50D / 200D
$1.38
25.49% below

Quick Summary

Puntos Clave

Negative free cash flow of -4.66 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-257.23%
Below sector avg (-51.02%)
ROICN/A
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio90.53
Interest CoverageN/A

Valoración

PE (TTM)
-4.14
Below sector avg (-1.98)
P/B Ratio5.73
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (44 pares)
Métrica Acción Mediana del Sector
P/E -4.1 -2.0
P/B 5.7 5.1
ROE % -257.2 -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -10.44 M
ROE -257.23% ROA -245.66%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -4.66 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 90.53
Interest Coverage N/A Asset Turnover N/A
Working Capital 7.51 M Tangible Book Value 7.55 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4.14 Forward P/E N/A
P/B Ratio 5.73 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -10.77%
Market Cap 43.28 M Enterprise Value 40.64 M
Per Share
EPS (Diluted TTM) -1.35 Revenue / Share N/A
FCF / Share -0.11 OCF / Share -0.11
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 44.64%
SBC-Adj. FCF -6.69 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023
Revenue — — —
Net Income -10.44 M -7.85 M -11.98 M
EPS (Diluted) -1.35 -0.51 -0.64
Gross Profit — — —
Operating Income — — —
EBITDA — — —
R&D Expenses 1.72 M 3.31 M 1.57 M
SG&A Expenses — — —
D&A — — —
Interest Expense 98,911.0 -165,669.0 3.46 M
Income Tax — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023
Total Assets 11.09 M 2.92 M 4.93 M
Total Liabilities 702,068.0 723,349.0 558,097.0
Shareholders' Equity 10.39 M 2.20 M 4.37 M
Total Debt — — —
Cash & Equivalents 6.35 M — —
Current Assets 11.06 M 2.89 M 4.86 M
Current Liabilities 702,068.0 723,349.0 558,097.0